Evidence map›Paper›PMID 33211271›Full record

ArticleActa parasitologica2021

Naloxone Diminishes the Virulence and Modifies the Cellular Immune Responses of BALB/c Mice Infected with Leishmania major.

Mohammad Hossein Alimohammadian, Farhad Riazi-Rad, Mahsa Asadi-Tat, Sima Darabi, Haiedeh Darabi, Vahid Khaze, Fariborz Bahrami, Soheila Ajdary

Abstract read
PubMed Publisher
In one paragraph

Article in Acta parasitologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mohammad Hossein AlimohammadianDepartment of Immunology, Pasteur Institute of Iran, 69 Pasteur Avenue, 13169-43551, Tehran, Iran. mhalimoham@gmail.com.ORCID http://orcid.org/0000-0003-3077-6638
Farhad Riazi-RadDepartment of Immunology, Pasteur Institute of Iran, 69 Pasteur Avenue, 13169-43551, Tehran, Iran.
Mahsa Asadi-TatDepartment of Immunology, Pasteur Institute of Iran, 69 Pasteur Avenue, 13169-43551, Tehran, Iran.
Sima DarabiDepartment of Immunology, Pasteur Institute of Iran, 69 Pasteur Avenue, 13169-43551, Tehran, Iran.
Haiedeh DarabiDepartment of Immunology, Pasteur Institute of Iran, 69 Pasteur Avenue, 13169-43551, Tehran, Iran.
Vahid KhazeDepartment of Immunology, Pasteur Institute of Iran, 69 Pasteur Avenue, 13169-43551, Tehran, Iran.
Fariborz BahramiDepartment of Immunology, Pasteur Institute of Iran, 69 Pasteur Avenue, 13169-43551, Tehran, Iran.
Soheila AjdaryDepartment of Immunology, Pasteur Institute of Iran, 69 Pasteur Avenue, 13169-43551, Tehran, Iran.
Pasteur Institute of Iran · IR

Funding

Pasteur Institute of Iran IPI-384
6 · The paper itself

Abstract

purposeLeishmania major-infected BALB/c mice display strong susceptibility to the infection due to the induction of Th2 response. The aim of this study was to assess the effects of naloxone on virulence of L. major in BALB/c mice and the ensued cellular immune response.

methodsThe effects of injection of a single dose of naloxone in the footpad of L. major-infected BALB/c mice were investigated by evaluating the lesion sizes, the parasite burden, cell proliferation, secreted cytokines (IFN-γ, IL-4, IL-10 and IL-12) and their genes expressions due to naloxone treatment while the untreated mice were used as a control.

resultsSignificantly lower lesion sizes and less parasite burden were measured in the treated mice. Significantly decreased productions of IFN-γ, IL-12, IL-4, and IL-10 were also observed in the treated mice at week 4 post-infection while the production IL-10 remained significantly hindered till 8 weeks post-infection.

conclusionOur data indicated that although the treatment of L. major-infected BALB/c mice with a single dose of naloxone was unable to improve the cellular immune response, it led to lower virulence, confirmed by significantly reduced lesions and parasite load.

Indexed as

Leishmania majorLeishmaniasis, CutaneousAnimalsImmunity, CellularMiceMice, Inbred BALB CNaloxoneVirulenceNaloxoneBALB/c miceCutaneous leishmaniasisLeishmania majorNaloxone

Identifiers

PMID33211271
OpenAlexW3102830597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.